טוען...
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
BACKGROUND: Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often dis...
שמור ב:
הוצא לאור ב: | Exp Hematol Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848808/ https://ncbi.nlm.nih.gov/pubmed/27127725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0041-6 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|